Clinical trials
Phase 4 Stroke trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
43 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 2 |
| 2005 | 1 |
| 2007 | 2 |
| 2008 | 1 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 5 |
| 2018 | 2 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 25 |
| Terminated | 8 |
| Recruiting | 4 |
| Withdrawn | 4 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The University of Texas Health Science Center, Houston | 4 |
| National Institute of Neurological Disorders and Stroke (NINDS) | 2 |
| Population Health Research Institute | 2 |
| University of Pittsburgh | 2 |
| Amgen | 1 |
| Avanir Pharmaceuticals | 1 |
| Biotronik, Inc. | 1 |
| Boehringer Ingelheim | 1 |
| Cedars-Sinai Medical Center | 1 |
| Cook County Health | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stroke | 43 |
| Atrial Fibrillation | 6 |
| Muscle Spasticity | 5 |
| Brain Injuries | 3 |
| Cardiovascular Diseases | 3 |
| Ischemic Attack, Transient | 3 |
| Atherosclerosis | 2 |
| Brain Injuries, Traumatic | 2 |
| Dementia | 2 |
| Myocardial Infarction | 2 |
Trials
Showing 1 to 25 of 43. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.